基本情報
- CAS
2079-78-9- 標準SMILES
C[N+](C)(C)CCCCCC[N+](C)(C)C.O=C([O-])[C@H](O)[C@@H](O)C(=O)O.O=C([O-])[C@H](O)[C@@H](O)C(=O)O- InChIKey
FBKYPSXTNBQAJW-WBPXWQEISA-L- 分子式
- C20H40N2O12
- 平均分子量
- 500.5 g/mol
- 単同位体質量
- 500.25812472
概要
See also: Hexamethonium (has active moiety).
名称と識別子
- 優先名称
- Hexamethonium Tartrate
- IUPAC
- bis((2R,3R)-2,3,4-trihydroxy-4-oxobutanoate);trimethyl-[6-(trimethylazaniumyl)hexyl]azanium
- 現地名
- N,N,N,N',N',N'-ヘキサメチル-1,6-ヘキサンジアミニウム·2[(2R,3R)-2,3-ジヒドロキシ水素ブタンジオアート]
- 英語名
- hexamethonium tartrate
- 分子式
- C16H34N2O6
- 分子量
- 350.45096
名称と別名
Hexamethonium tartrateEsotensylEsoniumVegolysen-THexamethonium bitartrate4U6FTZ422JRefChem:146070218-207-12079-78-9(2R,3R)-2,3,4-trihydroxy-4-oxobutanoate;trimethyl-[6-(trimethylazaniumyl)hexyl]azaniumUNII-4U6FTZ422JHexamethonium tartrate [BAN]
名称をさらに表示
ヘキサメトニウム二酒石酸塩エソニウムエソテンシルベゴリセンTN,N,N,N',N',N'-ヘキサメチル-1,6-ヘキサンジアミニウム·2[(2R,3R)-2,3-ジヒドロキシ水素ブタンジオアート]N,N,N,N′,N′,N′-ヘキサメチル-1,6-ヘキサンジアミニウム・2[(2R,3R)-2,3-ジヒドロキシ水素ブタンジオアート]Vegolysen T
EINECS 218-207-1Hexamethylenebistrimethylammonium di(hydrogen tartrate)Tartaric acid, hexamethylenebis(trimethylammonium)salt (2:1)HEXAMETHONIUM TARTRATE [MI]HEXAMETHONIUM TARTRATE [MART.]NS00081438Q27260508AMMONIUM, HEXAMETHYLENEBIS(TRIMETHYL-, TARTRATE (1:2)
データベース識別子
- CAS
2079-78-9
物性
構造計算による物性
- 極性表面積
- 236 Ų
- 水素結合供与体数
- 6
- 水素結合受容体数
- 12
- 回転可能結合数
- 11
- 重原子数
- 34
- 形式電荷
- 0
- 複雑度
- 268
化学と産業
薬理情報
MeSH Pharmacological Classification
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery.
Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.
サプライヤー3 社
陕西缔都医药化工有限公司029-029-81120477 17792793610 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
TargetMol中国（陶术生物）15002134094 · [email protected]
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…